SULFONES: AN IMPORTANT CLASS OF ORGANIC COMPOUNDS WITH DIVERSE BIOLOGICAL ACTIVITIES
Keywords:
Sulfone, Therapeutic agents, Biological activityAbstract
Sulfones have been studied broadly for various biological activities primarily as anti-inflammatory, antimicrobial, anticancer, anti-HIV, antimalarial, and anti-inflammatory. The review focused on the biological activity of various sulfones on different therapeutic targets. The aim of this review is to summarize the biological significance of sulfones, giving a comprehensive scenario and offer prospective in the development of new sulfone derivatives as therapeutic agents.
Â
Downloads
References
Tozkoparan B, Kupeli E, Yesilada E, Ertan M. Preparation of 5-aryl-3-alkylthio-l,2,4-triazoles and corresponding sulfones with antiinflammatory–analgesic activity. Bioorg Med Chem 2007;15:1808-14.
Hwang SH, Wagner KM, Morisseau C, Liu J-Y, Dong H, Wecksler AT, et al. Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase. J Med Chem 2011;54(8):3037-50.
Shaaban OG, Rizk OH, Bayad AE, El-Ashmawy IM. Synthesis of some 4,5-dihydrothieno[3,2-e][1,2,4]triazolo[4,3-a] pyrimidine-2-carboxamides as anti-inflammatory and analgesic agents. Open Med Chem J 2013;7:49-65.
Curti C, Laget M, Carle AO, Gellis A, Vanelle P. Rapid synthesis of sulfone derivatives as potential anti-infectious agents. Eur J Med Chem 2007;42:880-4.
Dixit Y, Dixit R, Gautam N, Gautam DC. Synthesis of bioactive fluorinated 10H-phenothiazines and their sulfone derivatives. E-J Chem 2008;5(S1):1063-8.
Kumar ABVK, Rao KSVK, Chandra MS, Subha MCS, Choi YL. Synthesis and antimicrobial evaluation of sulfides, sulfoxides, and sulfones. J Korean Soc Appl Biol Chem 2009;52(1):34-9.
Pilyugin VS, Kuznetsov SL, Sapozhnikov YE, Chikisheva GE, Kiseleva GV, Vorob’eva TP, et al. Synthesis and fungicidal activity of bis(2-arylcarbonylamino-1H-benzimidazol-5-yl) sulfones. Russ J Gen Chem 2008;78(3):446-50.
Stecoza CE, Caproiu MT, Draghici C, Chifiriuc MC, Dracea NO. Synthesis, characterization and antimicrobial activity evaluation of some new derivatives of 6,11-dihydrodibenzo[b,e]thiepin 5,5-dioxide. Rev Chem (Bucuresti) 2000;60(2):137-41.
Barbuceanu S, Almajan GL, Saramet I, Draghici C, Socoteanu R, Barbuceanu F. New S-alkylated 1,2,4-triazoles incorporating diphenylsulfone moieties with potential antibacterial activity. J Serb Chem Soc 2009;74(10):1041-9.
Kudryavtsev KV, Bentley ML, McCafferty DG. Probing of the cis-5-phenyl prolinescaffold as a platform for the synthesis of mechanism-based inhibitors of the Staphylococcus aureussortase Srt Aisoform. Bioorg Med Chem 2009;17(7):2886-93.
Low E, Kim B, Francavilla C, Shiau TP, Turtle ED, O’Mahony DJR. Structure stability/ activity relationship of sulfone stabilized N, N-dichloroamines. Bioorg Med Chem Lett 2011;21:3682-5.
Soni S, Seth M, Sah P. Synthesis and in-vitro antimicrobial evaluation of some novel phthalyl substituted aryl sulphones and sulphonamides. Res J Pharm Biol Chem Sci 2012;3(1):898-907.
Guruswamy B, Arul RK, Chaitanya MVSRK, Darsi SSPK. Synthesis and biological evaluation of novel βâ€hydroxybenzimidazolylsulfonefluoroquinolones by selective oxidation using ammonium molybdate catalyzed H2O2. Eur J Chem 2013;4(4):329-35.
Kumar LV, Naik PJ, Naveen M, Chandrasekhar T, Reddy AB, Penchalaiah N, et al. Synthesis and biological evaluation of some new 2,5-disubstituted 1,3,4-oxadiazoles from 3-(arylsulfonyl) propanehdrazides. Ind J Chem 2014;53B:208-11.
Wani A, Mahajan S. Synthesis, antibacterial activity and preliminary QSAR studies of diarylsulfones. Am J Pharm Tech Res 2014;4(1):1058-66.
Meadows DC, Sanchez T, Neamati N, North TW, Gervay-Hague J. Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1. Bioorg Med Chem 2007;15(2):1127-37.
Usera AR, Dolan P, Kensler TW, Posner GH. Novel alkyl side chain sulfone 1α,25-dihydroxyvitamin D3 analogs: a comparison of in vitro antiproliferative activities and in vivo calcemic activities. Bioorg Med Chem 2009;17(15):5627-31. b) Usera AR, Dolan P, Kensler TW, Posner GH. Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1α,25-dihydroxyvitamin D3:chemical synthesis and biological evaluation. Bioorg Med Chem 2007;15(16):5509-18.
Barbosa EG, Bega LAS, Beatriz A, Sarkar T, Hamel E, Amaral MS, et al. A diaryl sulfide, sulfoxide, and sulfone bearing structural similarities to combretastatin A-4. Eur J Med Chem 2009;44(6):2685-88.
Cohen A, Crozet MD, Rathelot P, Azas N, Vanelle P. Synthesis and promising in vitro antiproliferative activity of sulfones of a 5-nitrothiazole series. Mol 2013;18:97-113.
Al-Said MS, Ghorab MM, Nissan YM. Dapson in heterocyclic chemistry, part VII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biological active 1.3-dihydropyridine, chromene and chromenopyridine moieties. Chem Cent J 2012;6:64.
Rosenthal AS, Chen X, Liu JO, West DC, Hergenrother PJ, ShapiroT A, et al. Malaria-infected mice are cured by a single oral dose of new dimerictrioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. J Med Chem 2009;52(4): 1198-203.
Capela R, Oliveira R, Gonçalves LM, Domingos A, Gut J, Rosenthal PJ, et al. Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition. Bioorg Med Chem Lett 2009;19(12):3229-32.
Lee PJ, Bhonsle JB, Gaona HW, Huddler DP, Heady TN, Kreishman-Deitrick M, et al. Targeting the fatty acid biosynthesis enzyme, β-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. J Med Chem 2009;52(4):952-63.
Shenai BR, Lee BJ, Alvarez-Hernandez A, Chong PY, Emal CD, Neitz RJ, et al. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob Agents Chemother 2003;47(1):154-60.
Chen YT, Lira R, Hansell E, McKerrow JH, Roush WR. Synthesis of macrocyclictrypanosaomal cysteine protease inhibitors. Bioorg Med Chem Lett 2008;18(22):5860-63.
Brak K, Doyle PS, McKerrow JH, Ellman JA. Identification of a new class of nonpeptidic inhibitors of cruzain. J Am Chem Soc 2008;130(20):6404-10.
Chen YT, Brinen LS, Kerr ID, Hansell E, Doyle PS, McKerrow JH, et al. In vitro and in vivostudies of the trypanocidal properties of WRR-483 against Trypanosomacruzi. PLoS 2010;4(9):e825.
Bryant C, Kerr ID, Debnath M, Kenny KHA, Ratnam J, Ferreira RS, et al. Novel non-peptidicvinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg Med Chem Lett 2009;19(21):6218-21.
Bachovchin DA, Zuhl AM, Speers AE, Wolfe MR, Weerapana E, Brown SJ, et al. Discovery and optimization of sulfonylacrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1. J Med Chem 2011;54(14):5229-36.
Hwang JY, Huang W, Arnold LA, Huang R, Attia RR, Connelly M, et al. Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone. J Biol Chem 2011;286:11895-908.
Hwang JY, Attia RR, Zhu F, Yang L, Lemoff A, Jeffries C, et al. Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPT's) as thyroid hormone receptor-coactivator interaction inhibitors. J Med Chem 2012;55(5):2301-10.
Su X, Pradaux-Caggiano F, Vicker N, Thomas MP, Halem H, Culler MD, et al. Adamantylethanonepyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroiddehydrogenase type 1. Chem Med Chem 2011;6:1616-29.
Reid PR, Bridges TM, Sheffler DJ, Cho HP, Lewis LM, Days E, et al. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN Probe. Bioorg Med Chem Lett 2011;21(9):2697-701.
Strassmaier T, Karpen JW. Novel N7-and N1-substituted cGMP derivatives are potent activators of cyclic nucleotide-gated channels. J Med Chem 2007;50(17):4186-94.
Chen H, Tsalkova T, Chepurny OG, Mei FC, Holz GG, Cheng X, et al. Identification and characterization of small molecules as potent and specific EPAC2 antagonists. J Med Chem 2013;56(3):952-62.
Welker ME, Kulik G. Recent synthesis of PI3K/Akt/mTOR signaling pathway inhibitors. Bioorg Med Chem 2013;21(14):4063-91.
Wu P, Su Y, Liu X, Zhang L, Ye Y, Xu J, et al. Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors. Eur J Med Chem 2011;46:5540-8.
Finlay MRV, Buttar D, Critchlow SE, Dishington AP, Fillery SM, Fisher E, et al. Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor. Bioorg Med Chem Lett 2012;22:4163-8.
Liu KK.-C, Bailey S, Dinh DM, Lam H, LiC, Wells PA, et al. Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors. Bioorg Med Chem Lett 2012;22:5114-7.
Shaw D, Best J, Dinnell K, Nadin A, Shearman M, Pattison C, et al. 3,4-Fused cyclohexylsulfones as c-secretase inhibitors. Bioorg Med Chem Lett 2006;16:3073-7.
Setti EL, Reddy NAV, Phillips OA, Czajkowski DP, Atchison K, Atwal H, et al. Synthesis and β-lactamase inhibitory activity of 2β-alkoxycarbonylpenicillanic acid sulfones. J Antibiotics 1996;49(9):944-6.
Phillips OA, Reddy AVN, Setti EL, Spevak P, Czajkowski DP, Atwal H, et al. Synthesis and biological evaluation of penamsulfones as inhibitors of b-lactamases. Bioorg Med Chem 2005;13:2847-58.
Papp-Wallace KM, Bethel CR, Gootz TD, Shang W, Stroh J, Lau W, et al. Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone. Biochem Pharmacol 2012;83(4):462-71.
Nottingham M, Bethel CR, Pagadala SRR, Harry E, Pinto A, Lemons ZA, et al. Modification of the C6-substituent of penicillin sulfones with goal of improving inhibitor recognition and efficacy. Bioorg Med Chem Lett 2011;21(1):387-93.
Lee M, Hesek D, Shi Q, Noll BC, Fisher JF, Chang M, et al. Conformational analyses of thiirane-based gelatinase inhibitors. Bioorg Med Chem Lett 2008;18(10):3064-7.
Forbes C, Shi Q, Fisher JF, Lee M, Hesek D, Llarrull L, et al. Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases. Chem Biol Drug Des 2009;74(6):527-34.
Gooyit M, Lee M, Hesek D, Boggers B, Oliver AG, Fridman R, et al. Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethylthiiranes as potent gelatinase and MT1-MMP inhibitors. Chem Biol Drug Des 2009;74(6):535-46.
Gooyit M, Lee M, Schroeder VA, Ikejiri M, Suckow MA, Mobashery S, et al. Selective water-soluble gelatinase inhibitor prodrugs. J Med Chem 2011;54(19):6676-90.